HSP-Hospira Stock Research, Ratings, and Analysis

Hospira (hsp) Stock Research

Last Updated by WikiWealth | Update This Page Now

►Summary | Profile | News | Chart | SWOT | Cash Flow | Comps | Buffett | WACC

Long Term Rating Stock Ratings Help

BUY

SWOT Statistics hsp SWOT Analysis

Strengths + Opportunities = 3

Threats + Weaknesses = 3

Add your knowledge to the Hospira SWOT analysis.

Generic Strategy hsp Generic Strategy

Narrow Scope

Broad Scope

None

Uniqueness

Low Cost

Generic strategies categorize companies by the scope and the strength of their business. Hospira does not have a definable strategy, therefore, it risks losing out to firms that concentrate on one particular competitive advantage. (read more).

Company Description: Hospira Inc, founded in 2003 is a medical and pharmaceutical company that develops, manufactures and markets numerous specialty pharmaceutical products and medical delivery systems for hospitals, clinics, and home Healthcare providers both in the United States and internationally. In addition Hospira develops and manufactures critical care monitoring devices as well providing development and manufacturing services to pharmaceutical and biotechnology companies. Update

Market Research Update

Health Care Industry Research & Analysis: The health care industry depends on the care of health-related services by professionals for the benefit of patients. Medical device markers, insurance companies, pharmaceutical drug developers and government institutions are major participants in the treatment of sick, injured and disabled patients. Health Care Trading Strategy: Health Care stocks tend to be less sensitive to economic changes. Look for undervalued health care investments at any point in the business cycle when stock prices are low. However, biotech, employment staffing and insurance companies may all decrease during recessions for different reasons. Government intervention is another important factor in health care investments, since government spending in health care is a very large portion of overall health care spending. When governments change spending plans, different sub-sectors in the industry are significantly affected. Upward sloping stock charts and financial news may indicate a selling opportunity while the opposite means that stocks are becoming undervalued.

Industry Sub Sector: . Hospira is a dominant industry leader due to its personnel, experience and financial strengths. Industry leaders are difficult to compete against, which decreases business and investor risks. The market is quickly expanding. This lowers the threat of direct competition and increases Hospira's profits.

Market Challenges: Opportunities: Solutions:

Strategy Analysis Update

A culture that experiments produces better long term value. Hospira's experimentations yield new products and services that outpace competitive threats.

Strategy: Competitive Advantages:

Financial Analysis Update

Current Revenue Sources: Future Revenue Sources: